Ascentage Pharma Group International

Ascentage Pharma Group International

AAPG - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.12B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ascentage Pharma Group InternationalAscentage Pharma Group International-6.1--468%1.23.9

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.12 Billion
Enterprise Value$1.39 Billion
Earnings per Share$-13.56
Beta0.66
Outstanding Shares93,312,054

Return

Return on Equity-468.36%ROE
Return on Assets-80.41%
Return on Invested Capital-184.55%

Valuation & Multiples

P/E Ratio-6.13P/E Ratio
PEG-16.7PEG
Price to Sales1.2Price to Sales
Price to Book Ratio2.0Price to Book Ratio
Enterprise Value to Revenue1.35
Enterprise Value to EBIT-0.55
Enterprise Value to Net Income-1
Total Debt to Enterprise1.56
Debt to Equity3.89Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 18, 2026
EPS
-$1.30
Est. -$0.22
Revenue
$44.85 M
Est. $53.63 M

Next Earnings Call

Expected Date
March 31, 2027
EPS Estimate
-$0.30
Consensus analyst estimate
Revenue Estimate
$49.77 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.02%▼ 0.00%
Total Invested$238,263▼ 9.58%
Investors Holding10▲ 3.00%

About Ascentage Pharma Group International

767 employees
CEO: Dajun Yang

Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical cond...

Questions & Answers